Skip to main content
. Author manuscript; available in PMC: 2010 Aug 2.
Published in final edited form as: Hypertension. 2008 May 26;52(1):72–79. doi: 10.1161/HYPERTENSIONAHA.108.111427

Table 3.

Humoral factors

Variable Weight Loss (n=26) Control (n=14)
Baseline 16 Weeks Baseline 16 Weeks
C-reactive protein (mg/L) 2.3 ± 0.5 1.7 ± 0.4 2.0 ± 0.6 1.4 ± 0.3
Interleukin-6 (pg/ml) 1.2 ± 0.2 1.1 ± 0.1 1.0 ± 0.17 1.4 ± 0.2
Tumor-necrosis factor-α (pg/ml) 1.6 ± 0.2 1.4 ± 0.1 2.9 ± 1.1 2.5 ± 0.7
Oxidized LDL (U/L) 69 ± 4 57 ± 4* 65 ± 5 67 ± 4
Total antioxidant status (mg/dl) 1.34 ± 0.04 1.27 ± 0.04 1.33 ± 0.05 1.34 ± 0.06
Adiponectin (μg/ml) 11.7 ± 1.7 11.4 ± 1.4 8.0 ± 1.6 8.0 ± 1.5
Leptin (ng/ml) 17.6 ± 2.2 10.5 ± 1.9* 13.5 ± 1.5 14.5 ± 2.1
Norepinephrine (pg/ml) 209 ± 15 211 ± 25 167 ± 19 174 ± 18
Aldosterone (ng/dl) 5.6 ± 0.6 5.2 ± 0.8 7.0 ± 1.2 7.2 ± 1.3
Endothelin-1 (pg/ml) 6.6 ± 0.3 6.6 ± 0.3 5.9 ± 0.4 6.6 ± 0.4
Cortisol (μg/ml) 12.0 ± 1.0 9.8 ± 0.7 12.8 ± 1.3 10.0 ± 1.3
Free fatty acids (μmol/L) 715 ± 56 655 ± 47 577 ± 62 604 ± 66

Values are mean ± standard error;

*

P<0.05 vs. Pre;

P<0.05 group (Weight loss, Control) × time (Pre, Post) interaction.